Sonnet to merge into Hyperliquid Strategies, holding 12.6 million HYPE tokens and $300 million in cash
07-14 11:25

Odaily News Nasdaq-listed Sonnet BioTherapeutics announced that it will merge with Rorschach I LLC to form Hyperliquid Strategies and launch a crypto treasury strategy. The new entity will be renamed Hyperliquid Strategies and is expected to hold 12.6 million HYPE tokens and $305 million in cash, with a total valuation of approximately $888 million.
Rorschach I LLC was jointly established by Atlas Merchant Capital and Paradigm Operations and other sponsors. After the merger is completed, Hyperliquid Strategies will continue to be listed on Nasdaq and become a publicly traded company focused on crypto asset management, and the stock code will also be changed.
The transaction was supported by institutions such as Paradigm, Galaxy Digital, Pantera Capital, D1 Capital, Republic Digital and 683 Capital. (The Block)

最热快讯
资讯热榜
日榜
周榜
Data: Stablecoin market capitalization increased by $1.78 billion last week, a month-on-month increase of 0.67%.
Eugene: I almost sold my stocks at the bottom a few days ago, now I am focusing on the short-term opportunities in ETH
Analysis: Paradigm may hold approximately 19.13 million HYPE tokens, worth approximately $765.4 million
Planet Morning News | August 4
A whale increased its BTC long position and currently holds 752 BTC with a floating profit of $774,000
The suspected ETH reserve institution address has pledged more than 15,000 ETH, and the total pledged has exceeded 41,000 ETH